vs
ASTROTECH Corp（ASTC）与帕可Bio（PACB）财务数据对比。点击上方公司名可切换其他公司
帕可Bio的季度营收约是ASTROTECH Corp的301.7倍（$44.6M vs $148.0K）。帕可Bio净利率更高（-90.4% vs -2653.4%，领先2563.0%）。帕可Bio同比增速更快（13.8% vs -43.3%）。ASTROTECH Corp自由现金流更多（$-4.0M vs $-19.9M）。过去两年ASTROTECH Corp的营收复合增速更高（72.0% vs 7.3%）
航天科技公司（原名Spacehab Inc.）是一家总部位于美国得克萨斯州奥斯汀的科技孵化企业。该公司整合内部、研究机构、政府实验室及高校的技术资源，投资、孵化并退出初创企业，旗下子公司还为美国航空航天局、美国国防部、各国航天机构及全球商业客户提供商业化产品与服务。
太平洋生物科学（加利福尼亚）公司是2004年成立的美国生物技术企业，专注于研发生产基因测序相关设备，还可实现新型实时生物观测。公司拥有两大核心测序平台：基于零模波导特性的单分子实时测序平台（SMRT），以及采用天然核苷酸、无损伤掺入完成DNA结合与延伸的结合测序技术（SBB）平台。
ASTC vs PACB — 直观对比
营收规模更大
PACB
是对方的301.7倍
$148.0K
营收增速更快
PACB
高出57.1%
-43.3%
净利率更高
PACB
高出2563.0%
-2653.4%
自由现金流更多
ASTC
多$16.0M
$-19.9M
两年增速更快
ASTC
近两年复合增速
7.3%
损益表 — Q2 2026 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $148.0K | $44.6M |
| 净利润 | $-3.9M | $-40.4M |
| 毛利率 | 5.4% | 37.1% |
| 营业利润率 | -2635.8% | -92.3% |
| 净利率 | -2653.4% | -90.4% |
| 营收同比 | -43.3% | 13.8% |
| 净利润同比 | 2.0% | -1802.7% |
| 每股收益（稀释后） | — | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTCPACB
| Q4 25 | $148.0K | $44.6M | ||
| Q3 25 | $297.0K | $38.4M | ||
| Q2 25 | $220.0K | $39.8M | ||
| Q1 25 | $534.0K | $37.2M | ||
| Q4 24 | $261.0K | $39.2M | ||
| Q3 24 | $34.0K | $40.0M | ||
| Q2 24 | $74.0K | $36.0M | ||
| Q1 24 | $50.0K | $38.8M |
净利润ASTCPACB
| Q4 25 | $-3.9M | $-40.4M | ||
| Q3 25 | $-3.5M | $-38.0M | ||
| Q2 25 | $-2.9M | $-41.9M | ||
| Q1 25 | $-3.6M | $-426.1M | ||
| Q4 24 | $-4.0M | $2.4M | ||
| Q3 24 | $-3.3M | $-60.7M | ||
| Q2 24 | $-3.0M | $-173.3M | ||
| Q1 24 | $-3.2M | $-78.2M |
毛利率ASTCPACB
| Q4 25 | 5.4% | 37.1% | ||
| Q3 25 | 63.3% | 41.4% | ||
| Q2 25 | 33.6% | 36.9% | ||
| Q1 25 | 44.4% | -3.7% | ||
| Q4 24 | 59.4% | 25.6% | ||
| Q3 24 | 26.5% | 25.0% | ||
| Q2 24 | 37.8% | 16.5% | ||
| Q1 24 | 16.0% | 29.1% |
营业利润率ASTCPACB
| Q4 25 | -2635.8% | -92.3% | ||
| Q3 25 | -1190.6% | -101.1% | ||
| Q2 25 | -1326.4% | -112.8% | ||
| Q1 25 | -724.2% | -1154.5% | ||
| Q4 24 | -1655.6% | -390.1% | ||
| Q3 24 | -10670.6% | -160.3% | ||
| Q2 24 | -4518.9% | -488.3% | ||
| Q1 24 | -7066.0% | -209.6% |
净利率ASTCPACB
| Q4 25 | -2653.4% | -90.4% | ||
| Q3 25 | -1166.7% | -98.9% | ||
| Q2 25 | -1331.8% | -105.4% | ||
| Q1 25 | -680.3% | -1146.8% | ||
| Q4 24 | -1536.0% | 6.0% | ||
| Q3 24 | -9641.2% | -151.9% | ||
| Q2 24 | -3998.6% | -481.3% | ||
| Q1 24 | -6308.0% | -201.4% |
每股收益（稀释后）ASTCPACB
| Q4 25 | — | $-0.11 | ||
| Q3 25 | — | $-0.13 | ||
| Q2 25 | — | $-0.14 | ||
| Q1 25 | — | $-1.44 | ||
| Q4 24 | — | $-0.44 | ||
| Q3 24 | — | $-0.22 | ||
| Q2 24 | — | $-0.64 | ||
| Q1 24 | — | $-0.29 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $7.0M | $279.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $15.5M | $5.3M |
| 总资产 | $19.7M | $784.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTCPACB
| Q4 25 | $7.0M | $279.5M | ||
| Q3 25 | $11.3M | $298.7M | ||
| Q2 25 | $15.1M | $314.7M | ||
| Q1 25 | $18.1M | $343.1M | ||
| Q4 24 | $21.5M | $389.9M | ||
| Q3 24 | $21.8M | $471.1M | ||
| Q2 24 | $42.9M | $509.8M | ||
| Q1 24 | $52.4M | $561.9M |
股东权益ASTCPACB
| Q4 25 | $15.5M | $5.3M | ||
| Q3 25 | $19.1M | $36.1M | ||
| Q2 25 | $22.1M | $61.5M | ||
| Q1 25 | $24.8M | $91.6M | ||
| Q4 24 | $28.1M | $506.6M | ||
| Q3 24 | $32.1M | $453.1M | ||
| Q2 24 | $34.8M | $492.7M | ||
| Q1 24 | $37.6M | $649.0M |
总资产ASTCPACB
| Q4 25 | $19.7M | $784.1M | ||
| Q3 25 | $23.2M | $803.2M | ||
| Q2 25 | $27.0M | $825.5M | ||
| Q1 25 | $27.5M | $860.8M | ||
| Q4 24 | $31.0M | $1.3B | ||
| Q3 24 | $34.4M | $1.5B | ||
| Q2 24 | $37.6M | $1.5B | ||
| Q1 24 | $40.2M | $1.7B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-3.5M | $-19.1M |
| 自由现金流经营现金流 - 资本支出 | $-4.0M | $-19.9M |
| 自由现金流率自由现金流/营收 | -2671.6% | -44.6% |
| 资本支出强度资本支出/营收 | 277.7% | 1.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-14.9M | $-114.1M |
8季度趋势，按日历期对齐
经营现金流ASTCPACB
| Q4 25 | $-3.5M | $-19.1M | ||
| Q3 25 | $-3.9M | $-18.7M | ||
| Q2 25 | $-2.4M | $-29.4M | ||
| Q1 25 | $-3.9M | $-44.1M | ||
| Q4 24 | $-3.0M | $-30.6M | ||
| Q3 24 | $-3.7M | $-45.5M | ||
| Q2 24 | $-2.5M | $-54.3M | ||
| Q1 24 | $-2.3M | $-75.7M |
自由现金流ASTCPACB
| Q4 25 | $-4.0M | $-19.9M | ||
| Q3 25 | $-4.4M | $-18.8M | ||
| Q2 25 | $-2.7M | $-29.9M | ||
| Q1 25 | $-3.9M | $-45.4M | ||
| Q4 24 | $-3.4M | $-32.3M | ||
| Q3 24 | $-3.9M | $-46.3M | ||
| Q2 24 | $-2.8M | $-55.7M | ||
| Q1 24 | $-2.5M | $-79.6M |
自由现金流率ASTCPACB
| Q4 25 | -2671.6% | -44.6% | ||
| Q3 25 | -1476.1% | -48.9% | ||
| Q2 25 | -1231.4% | -75.3% | ||
| Q1 25 | -728.1% | -122.3% | ||
| Q4 24 | -1288.5% | -82.3% | ||
| Q3 24 | -11408.8% | -115.7% | ||
| Q2 24 | -3728.4% | -154.8% | ||
| Q1 24 | -5036.0% | -205.0% |
资本支出强度ASTCPACB
| Q4 25 | 277.7% | 1.9% | ||
| Q3 25 | 150.8% | 0.2% | ||
| Q2 25 | 158.2% | 1.4% | ||
| Q1 25 | 5.1% | 3.7% | ||
| Q4 24 | 122.2% | 4.1% | ||
| Q3 24 | 567.6% | 2.0% | ||
| Q2 24 | 305.4% | 4.1% | ||
| Q1 24 | 352.0% | 10.0% |
现金转化率ASTCPACB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -12.93× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTC
暂无分部数据
PACB
| Products | $39.0M | 87% |
| Service And Other | $5.7M | 13% |
